Navigation Links
Nottingham expertise in major European drug discovery partnership
Date:1/24/2013

Scientists from Nottingham are part of a major European-wide project aimed at developing the next generation of medicines that are more effective and longer lasting.

The academics from The University of Nottingham are using high-tech laser technology to study in real-time how drug molecules 'stick' to receptors or proteins on the surface of cells in our body in an effort to learn more about how drugs work.

Learning how drugs interact with the cells in our body could lead to further clues on how to design drugs for chronic and life threatening illnesses, such as cancer and asthma, which are better at treating patients and don't have to be taken as regularly as current therapies.

Professor Steve Hill, in the University's School of Biomedical Sciences, is leading the Nottingham side of the project. He said: "The ultimate aim here is to find new ways of interacting with some of those receptors which might form better drugs.

"Nottingham's expertise is in using clever ways to visualise in real-time the speed at which drugs bind and unbind to proteins in the body and to learn about how adding other drugs at the same time may improve or inhibit that.

"The goal will be to develop new medicines that patients don't have to remember to take twice or three times a day or with a meal just one dose a day would be enough."

Bench to bedside

Nottingham is part of a new 18m consortium supported by Europe's Innovative Medicines Initiative (IMI) and major pharmaceutical companies aimed at tackling the development of new drugs. During the course of the five-year project around 500,000 of that funding will come to Nottingham.

Almost 90 per cent of experimental drugs that are tested through expensive clinical trials fail at the final hurdle because they don't work as well as they should. In fact, only one in around 15,000 potential new drugs will make it to market a process that can take almost 15 years fr
'/>"/>

Contact: Emma Thorne
emma.thorne@nottingham.ac.uk
44-011-595-15793
University of Nottingham
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Anthropological expertise facilitates multicultural womens health care
2. Major step toward an Alzheimers vaccine
3. Majority of Americans say new Congress should take immediate action to expand medical research
4. McGill University Launches a Major New Study on HPV Prevention Using Divine 9 Personal Lubricants with Carragel
5. Medical Researcher Examines Alternatives to Major Surgery
6. Kettlebell Expert Lorna Kleidman Responds to the Rise in Fitness Parks throughout Major Cities
7. The Majority of Consumers Select TANCS® When Purchasing a Ladybug Vapor Steam Cleaner, Announces 1-800-GO-VAPOR.com
8. U of T Researchers uncover major source of evolutionary differences among species
9. Dr. Farshchian: Muscle Atrophy a Major Problem with Arthritis, is Now Being Treated with Regenerative Medicine
10. Dr. Farshchian: Muscle Atrophy a Major Problem with Arthritis, is Being Treated with Cell Therapy at the Center for Regenerative Medicine
11. Majority of Biggest U.S. Cities Now Smoke-Free
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , ... July 01, 2015 , ... ... compensation law has just published a top ten list they hope will guide ... Click here to read it now. , More than 450 ...
(Date:7/1/2015)... ... ... Francesca Camp wasn’t always a steadfast supporter of plastic surgery. But just as ... the practice; a terrible car accident years ago left her injured and in need of ... ? (And What if I Do?): Answers to All Your Questions about Plastic Surgery” (published ...
(Date:7/1/2015)... ... July 01, 2015 , ... After conducting a nationwide ... Tri-City Medical Center in Oceanside, Calif., has hired Cheryle Bernard-Shaw as chief ... compliance adaptation efforts and growing a focus on risk management, Bernard-Shaw will assume ...
(Date:7/1/2015)... ... ... Incentivizing the use of generic drugs has been an easy way for ... 90% off the prices for the brand-name products. But now that generics are experiencing ... of these high-cost generic drugs. The July issue of Atlantic Information Services, Inc.’s (AIS) ...
(Date:7/1/2015)... Beach, CA (PRWEB) , ... July 01, 2015 ... ... has returned to the Northbound team as Director of Referral Relations. , ... programs, including Northbound’s Collegebound, where she designed and implemented unique academic curriculum for ...
Breaking Medicine News(10 mins):Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Francesca Camp’s New Book Unmasks Plastic Surgery Advice 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2
... that blood tests which were designed to be detect heart attack ... or blood pressure tests and not superior to them, in terms ... been making too much of substances in the blood which they ... C-reactive protein, or CRP; homocysteine; and BNP, or B-type natriuretic peptide. ...
... the people of India constitute more than one-sixth ... underrepresented in studies related //to genetic diseases. And ... associated with urban and western lifestyles have risen ... studies of particular importance. ,In response ...
... number of heat-related deaths is underestimated and underreported in ... published in Biomedical Market Newsletter//(R). ,A new ... heat-related deaths is actually 54% higher than previously reported. ... as a contributing cause of death increased by 54% ...
... greying process continues with gusto into the 21st century. The ... with tantalising// appeal. The latest from scientists from Pittsburgh is ... within a living cell gets damaged, it may advance the ... the cell is too weak to help itself to rejuvenate ...
... Canada: Doctors are experiencing a nationwide shortage of donated skin, ... month, due to shortage of skin at Sunnybrook health sciences ... treating a man with severe burns in more than 80% ... body’s largest organs, protects us against infections caused by fire. ...
... Mice with neuroblastoma tumors have been successfully treated with ... and activated a chemotherapy drug directly at// those sites, ... and their colleagues at City of Hope National Medical ... (Vancouver, Canada). Neuroblastoma is a solid tumor that arises ...
Cached Medicine News:Health News:Researchers Make Progress in Studying Genetic Traits of India-born Populations 2Health News:Clues to Allay Aging 2Health News:Genetically Modified Cells Attack Tumors 2Health News:Genetically Modified Cells Attack Tumors 3
(Date:7/1/2015)... MENLO PARK, Calif. , July 1, 2015 /PRNewswire/ ... of its previously announced underwritten public offering of 3,636,364 ... the public of $2.75 per share. BioPharmX has granted ... 545,454 additional shares of common stock at the public ... Overseas Expansion Platform Fund, an existing stockholder, has agreed ...
(Date:7/1/2015)... , July 1, 2015 ... is expected to reach USD 49,119.2 million by 2020, ... Inc. Monitoring services is expected to remain the dominant ... USD 1,227.5 million in 2012, and an estimated CAGR ... (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , Browse full ...
(Date:7/1/2015)... July 1, 2015 The Haselmeier ... Board. Mr. Gert Weber has been nominated ... as Chief Executive Officer (CEO) of the ... st , 2015. Mr. Weber brings more than 20 ... and has filled various executive management positions, the last ...
Breaking Medicine Technology:BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 2mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 3mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 4mHealth Market Worth $ 49,119.2 Million By 2020: Grand View Research, Inc. 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
... June 14 Codexis, Inc. (Nasdaq: CDXS) today ... received the Ernst & Young Entrepreneur Of The Year ® 2010 ... , , ... LLP, the award recognizes outstanding entrepreneurs who are building and leading dynamic, ...
... , June 14 /PRNewswire-Asia/ -- Chindex International, Inc.,(Nasdaq: CHDX ... the People,s Republic of China , today announced,financial results for the ... , Financial Highlights:, -- Revenue of ... income up 76.6% year over year to $14.4 million in the fiscal, ...
Cached Medicine Technology:Codexis CEO Alan Shaw Named Ernst & Young Entrepreneur Of The Year® 2010 Recipient in Northern California 2Codexis CEO Alan Shaw Named Ernst & Young Entrepreneur Of The Year® 2010 Recipient in Northern California 3Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 11Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 12Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 13Chindex International, Inc. Reports Fourth Quarter and Full Year Fiscal 2010 Financial Results 14
Tungsten Carbide wire twister....
Designed to have a shock-absorbing force, providing less bounce or wasted force....
Osteophyte periosteal elevator for bone removing....
Angled ring curette....
Medicine Products: